Research advances in tumor radiosensitization mediated by topoisomerase inhibitors / 中华放射医学与防护杂志
Chinese Journal of Radiological Medicine and Protection
; (12): 466-470, 2018.
Article
en Zh
| WPRIM
| ID: wpr-708090
Biblioteca responsable:
WPRO
ABSTRACT
As anticancer drugs,topoisomerase inhibitors have been widely used in clinical practice,and their radiosensitivity has been gradually recognized.Many topoisomerase inhibitors are currently in pre-clinical and clinical studies.Several studies have shown that some topoisomerase inhibitors may be potential ideal radiosensitizers.However,the physico-chemical properties,toxicity and sensitization effects should be further investigated.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Radiological Medicine and Protection
Año:
2018
Tipo del documento:
Article